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Background: Polycyclic aromatic polyketides, such as the tetracyclines and
anthracyclines, are synthesized by bacterial aromatic polyketide synthases
(PKSs). Such PKSs contain a single set of iteratively used individual proteins for
the construction of a highly labile poly-L-carbonyl intermediate that is cyclized by
associated enzymes to the core aromatic polyketide. A unique polyketide
biosynthetic pathway recently identi¢ed in the marine strain `Streptomyces
maritimus' deviates from the normal aromatic PKS model in the generation of a
diverse series of chiral, non-aromatic polyketides.
Results: A 21.3 kb gene cluster encoding the biosynthesis of the enterocin and
wailupemycin family of polyketides from `S. maritimus' has been cloned and
sequenced. The biosynthesis of these structurally diverse polyketides is encoded
on a 20 open reading frames gene set containing a centrally located aromatic
PKS. The architecture of this novel type II gene set differs from all other aromatic
PKS clusters by the absence of cyclase and aromatase encoding genes and the
presence of genes encoding the biosynthesis and attachment of the unique
benzoyl-CoA starter unit. In addition to the previously reported heterologous
expression of the gene set, in vitro and in vivo expression studies with the
cytochrome P-450 EncR and the ketoreductase EncD, respectively, support the
involvement of the cloned genes in enterocin biosynthesis.
Conclusions: The enterocin biosynthesis gene cluster represents the most
versatile type II PKS system investigated to date. A large series of divergent
metabolites are naturally generated from the single biochemical pathway, which
has several metabolic options for creating structural diversity. The absence of
cyclase and aromatase gene products and the involvement of an oxygenase-
catalyzed Favorskii-like rearrangement provide insight into the observed
spontaneity of this pathway. This system provides the foundation for engineering
hybrid expression sets in the generation of structurally novel compounds for use
in drug discovery.
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Introduction
Bacterial aromatic polyketides, such as the clinically im-
portant metabolites oxytetracycline, doxorubicin and mi-
thramycin, represent a large group of biologically active
natural products. Although well over 500 in number, these
multicyclic aromatic polyketides have largely been charac-
terized from actinomycetes and belong to just a few
common structural types that include benzoisochromane-
quinones, tetracyclines, angucyclines, anthracyclines, tetra-
cenomycins and aureolic acids. Representative biosyn-
thetic gene clusters have been cloned and sequenced
from each group and belong to a homologous family called
the aromatic or type II polyketide synthases (PKSs) [1,2].
Each PKS contains a single set of iteratively used individ-
ual proteins (the two L-ketoacyl:acyl carrier protein (ACP)
synthase subunits KSK and KSL, an ACP, and possibly a
malonyl-CoA:ACP transacylase) for the construction of an
unmodi¢ed polyketide chain. Associated proteins reduce
(via ketoreductases (KRs)) and cyclize (via cyclases and
aromatases) the highly labile linear poly-L-ketoacyl thioest-
er intermediate. Nature only provides a few different core
polyketide structures by varying the chain length, position
of the ketoreduction, and regiochemistry of the cyclization
events. Structural diversity within the aromatic polyketides
is rather dictated by tailoring enzymes, such as oxygenases,
methylases, and glycosylases, during post-cyclization
events.
We recently described an unprecedented type II PKS gene
set from the marine isolate ‘Streptomyces maritimus’ that
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encodes the biosynthesis of a diverse series of three-
dimensionally, rigid polyketides known as the enterocins
and wailupemycins (Figure 1) [3]. This series of structur-
ally diverse bacteriostatic agents is derived from a single
biosynthetic pathway with numerous metabolic options.
The branched octaketide enterocin is the major metabolite
produced by ‘S. maritimus’ [4] and has additionally been
identi¢ed from edaphic streptomycetes [5^7] and a marine
invertebrate [8]. Enterocin is derived from an uncommon
benzoate starter unit and seven malonate molecules and
undergoes a rare Favorskii-like rearrangement [7]. 5-De-
oxyenterocin and 3-epi-5-deoxyenterocin differ from enter-
ocin only in hydroxyl group functionalization at C5 and the
stereochemistry at C3. Three additional K-pyrone contain-
ing metabolites, wailupemycins A^C [4], are probably
derived from a common branched intermediate that decar-
boxylates to yield the structurally diverse set. Wailupemy-
cin D, on the other hand, is derived from a common pre-
rearranged polyketide intermediate [3].
Heterologous expression of the enterocin (enc) biosynthesis
gene cluster from ‘S. maritimus’ in the genetically engi-
neered host strain Streptomyces lividans K4-114 [9] veri¢ed
that all of the genetic information for the production of the
enterocin^wailupemycin series was contained on the cos-
mid clone pJP15F11 [3]. The enc cluster represents the
most versatile type II PKS system investigated to date as
at least six divergent compounds are derived from this
single cluster. Its novel features provide the foundation
for engineering hybrid expression systems with more typ-
ical type II PKS gene sets in the generation of diverse
ranges of novel compounds for use in drug discovery.
Hence, we performed a detailed analysis of the enc biosyn-
thetic gene cluster in ‘S. maritimus’. The sequence in-
cludes not only the genes encoding polyketide assembly,
but also for the formation of the novel benzoate starter
unit. In addition, this is the ¢rst report of the genetic orga-
nization of a secondary metabolic gene cluster from a ma-
rine actinomycete.
Figure 1. Proposed biosynthetic pathway from benzoyl-CoA to enterocin and the wailupemycins.
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Results
Cloning and sequencing of the enc cluster
The common K-pyrone residue in the enterocins and wai-
lupemycins is a regular feature of many mutant and re-
combinant polyketides generated from type II PKS sys-
tems and served to indicate that this series of
metabolites is probably synthesized via an aberrant type
II rather than a modular type I polyketide pathway. Con-
sequently, we initially speculated that the enterocin/wailu-
pemycin biosynthesis gene cluster contained homologues
to actI (minimal PKS) and actIII (KR) genes from the acti-
norhodin pathway of Streptomyces coelicolor A3(2) [10]. A ‘S.
maritimus’ cosmid library was thus constructed in SuperCos
I and screened with a digoxigenin-labeled actI-ORF1
(KSK) probe. Restriction mapping of the positive cosmids
revealed three distinct type II PKS gene sets in the ge-
nome. Two of these clusters additionally hybridized to the
actIII probe. Spot sequencing of both clusters veri¢ed the
presence of type II PKS genes and further revealed the
presence of putative genes encoding a phenylalanine am-
monia lyase (PAL) and a benzoyl-CoA ligase on cosmid
pSS9A6. Since these genes are probably involved in the
synthesis of the unique benzoyl-CoA starter unit, we se-
lected pSS9A6 for further analysis. The identi¢cation of
the enc cluster on this cosmid was con¢rmed by the suc-
cessful expression of the entire enterocin gene cluster from
the pSS9A6 homologue pJP15F11, a derivative of the Es-
cherichia coli^Streptomyces shuttle cosmid pOJ446, in S. livi-
dans K4-114 [3].
A contiguous 21.3 kb region of pSS9A6 was fully se-
quenced on both strands. The nucleotide (nt) sequence
was deposited at GenBank under the accession number
AF254925. The sequence was analyzed for putative open
reading frames (ORFs) with the FRAME program [11] and
aligned with homologous sequences in the databases.
Twenty putative complete ORFs were designated encA
through encT and consist of at least 14 probable structural
genes and four regulation and resistance genes (Figure 2,
Table 1). All ORFs are preceded by putative ribosome-
binding sites with common consensus motifs [12]. The
sequence showed the typical GC content for Streptomyces
DNA at 68.8% in the coding region. Flanking the encE and
encT genes are ORFs with high homology to hypothetical
proteins of unknown functions and to housekeeping pro-
teins, thus delineating the boundaries of the enc gene clus-
ter.
Probable PKS genes
The minimal enc PKS, EncABC, is encoded by a set of
genes architecturally similar to most other type II PKS
clusters and is centrally located in the cluster. EncA is
either translated from a 1272 nt ORF, starting with a
GTG codon, or from an ATG codon 51 nt further up-
stream. Both start codons are preceded by convincing pu-
tative ribosome-binding sites at appropriate distances. The
protein sequence of the KSK homologous EncA contains a
candidate residue for the active cysteine residue at position
170 or 187, respectively, that anchors the acyl group during
chain procession, as well as the conserved acyltransferase
(AT) motif GHS 178 aa further downstream [10]. Overlap-
ping the encA stop codon by 4 nt, encB encodes a protein of
407 aa in length with strong homology to KSL enzymes. As
in other type II PKS systems, the KSL EncB exhibits se-
Figure 2. Organization of the enterocin biosynthetic gene cluster (enc) in `S. maritimus'. Each arrow represents the direction of
transcription of an ORF.
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quence similarity to the KSK EncA and has a glutamine
substituted for the conserved cysteine residue. In agree-
ment with the structure of enterocin, EncB is most homol-
ogous to KSL proteins involved in the biosynthesis of other
octaketides, such as actinorhodin, frenolicin, and nogalamy-
cin. The third enzyme of the minimal enc PKS is encoded
by encC, an ORF of 249 nt, which bears signi¢cant simi-
larity on an amino acid level to ACPs. The putative 4P-
phosphopantetheine-binding serine residue is located at
position 39 within a highly conserved region of the protein
sequence [10].
Adjacent to the putative minimal enc PKS in an upstream
direction, encD shows good homology to KR genes. The
protein contains the characteristic short-chain alcohol de-
hydrogenase signature sequence between aa 148 and 167
(PROSITE: PS00061). As with most other KRs associated
with type II PKSs, EncD probably catalyzes the reduction
of the C-9 keto group of the nascent polyketide chain.
Notably absent, however, is the presence of cyclase or
aromatase genes that typify aromatic PKS gene sets. These
gene products are integral components of these systems
and direct the cyclization mode of the highly reactive
open chain polyketide precursor by performing regiospe-
ci¢c aldol reactions. This signi¢cant architectural difference
between the enc cluster and all known bacterial type II
PKS gene clusters provides partial insight to the observed
spontaneity of the enc pathway.
Genes putatively involved in starter unit synthesis and
attachment
The benzyl moiety in enterocin is derived from the rare
bacterial PKS starter unit benzoic acid [7,13]. ORFs puta-
tively involved in the biosynthesis of the benzoyl-CoA
starter unit are arranged on either side of the minimal
PKS on four transcripts. The ¢rst step in the proposed
benzoic acid biosynthetic pathway in ‘S. maritimus’ (Figure
3) involves the gene product of encP which shows signi¢-
cant homology to PALs and histidine ammonia lyases (his-
tidases, HALs) (Table 1). EncP contains a conserved motif
around Ser144, which is the probable precursor of the modi-
¢ed dehydroalanine residue in the 4-methylidene-imida-
zol-5-one prosthetic group [14]. Sequence analysis further
suggests that EncP functions as a PAL and not a HAL,
which is consistent with benzoate synthesis in plants where
PAL catalyzes the initial pathway reaction, the conversion
of L-phenylalanine to trans-cinnamic acid [14,15]. In strik-
ing contrast to the high number of known PALs from
plants and fungi, a bacterial PAL gene or protein has pre-
viously not been described. Activation of cinnamic acid to
its CoA thioester is proposed as the second biosynthetic
reaction in this series and is probably catalyzed by the encH
gene product. EncH is homologous to long-chain fatty
acid-CoA ligases (Figure 4) and contains a putative AMP-
binding site (Pfam: PDOC00427). The deduced protein
sequences of encI and encJ show high similarities to eno-
yl-CoA hydratases and L-ketothiolases (acyl-CoA acetyl-
transferase), respectively. Among the closest relatives of
EncJ is the uncharacterized enzyme PaaJ from the phenyl-
Table 1
Deduced functions of the ORFs in Figure 2.
Protein Amino
acids
(no.)
Proposed function Sequence similarity
(protein, origin)
Similarity/identity
(%)
Protein accession
number
Reference
EncA 423 KSK NcnA, Streptomyces arenae 80%/66% AAD20267 [68]
EncB 407 KSL Frn2, S. roseofulvus 68%/57% AAA19617 [22]
EncC 82 ACP ActI ORF3, S. coelicolor 65%/43% CAA45045 [10]
EncD 266 KR AknIII, Streptomyces galilaeus 73%/59% BAA03128 [69]
EncE 163 Regulatory protein NolA, Bradyrhizobium elkanii 64%/44% P50329 [70]
EncF 283 Transcriptional activator FrnG, S. roseofulvus 62%/46% AAC18102 [22]
EncG 163 Unknown MtmX, Streptomyces argillaceus 51%/37% S58172 [38]
EncH 535 Acyl-CoA ligase CaiC, E. coli 51%/33% I41013 [71]
EncI 258 Enoyl-CoA hydratase YngF, B. subtilis 52%/35% CAA74218 [72]
EncJ 400 L-Oxoacyl-CoA thiolase PaaJ, E. coli 42%/29% CAA66099 [16]
EncK 241 Methyltransferase (MT) PemT, A. aceti 40%/26% BAA34057
EncL 340 AT DpsD, S. peucetius 57%/43% AAA65209 [21]
EncM 464 FAD-dependent oxygenase MitR, S. lavendulae 48%/34% AAD28454 [25]
EncN 522 Aryl-CoA ligase BadA, R. palustris 57%/41% AAA92151 [17]
EncO 130 Unknown
EncP 523 PAL HutH, B. subtilis 58%/37% P10944 [73]
PAL, Trifolium subterraneum 52%/31% P45734 [74]
EncQ 81 Ferredoxin RapO, Streptomyces hygroscopicus 54%/44% CAA60464 [28]
EncR 401 Cytochrome P-450
hydroxylase
Orf3, S. lavendulae 60%/47% AAD28449 [25]
EncS 215 Regulatory protein BetI, E. coli 43%/26% P17446 [75]
EncT 482 Ef£ux protein CmcT, S. lactamdurans 55%/43% Q04733 [33]
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Figure 3. Possible biosynthetic pathways leading to benzoic acid in `S. maritimus'. Route A, L-oxidative degradation; route B, retro-aldol
degradation with a possible additional chain extension performed by the thiolase EncJ.
Figure 4. Phylogenetic tree of EncH, EncN
and related acyl- and aryl-CoA ligases.
Sequences were retrieved from GenBank
(accession numbers given in parentheses)
and aligned with ClustalX. The scale bar
indicates 0.1 changes per nt.
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acetate degradation pathway of E. coli [16], which suggests
a structurally related substrate for EncJ. Homologues to
EncH, EncI, and EncJ are typically constituents of L-oxi-
dation pathways, implying a similar route for cinnamate
degradation to benzoate. However, a corresponding ORF
encoding a hydroxyacyl-CoA dehydrogenase, the fourth
protein necessary for a complete L-oxidation series, was
not identi¢ed in the enc cluster.
Database searches revealed two ORFs that may function in
the activation and transfer of the benzoate starter unit. The
acyl-CoA ligase EncN putatively functions in the activation
of the benzoate starter unit. The putative protein has high-
est homology to aryl-CoA ligases, such as BadA and HbaA
from Rhodopseudomonas palustris, which activate benzoate
[17] and hydroxybenzoate [18], respectively, and ORF8
from the 3-chlorobenzoate degradation cluster in an Alcali-
genes sp. [19] (Figure 4). EncN also shows good homology
to the CoA ligase domain from RifA [20], which is involved
in the selection of the 3-amino-5-hydroxybenzoic acid
starter unit for the rifamycin PKS. As with EncH, the de-
duced protein of EncN contains the amino acid motif of an
AMP-binding domain common to CoA ligases. A second
enzyme that has been postulated in the selection of non-
acetate starter units is the AT. A counterpart to this protein
was also found in the enc cluster, represented by the 340 aa
gene product of encL, located immediately downstream of
the putative ACP. This gene product is similar to AT pro-
teins or domains of polyketide and fatty acid synthases and
putatively catalyzes the transfer of benzoyl-CoA onto the
ACP. The sequence features the conserved GHS motif
that is probably involved in the formation of the acyl-en-
zyme intermediate. EncL is most similar to the daunoru-
bicin DpsD [21] and the frenolicin FrnK [22] ATs, which
participate in the transfer of non-acetate starter unit acyl-
CoAs in type II PKS systems.
Putative tailoring genes
The biosynthesis of enterocin probably involves two oxi-
dative reactions that are catalyzed by separate tailoring
enzymes. The Favorskii-like rearrangement is unprece-
dented in post-type II PKS assembly and putatively in-
volves the oxidative rearrangement of the highly reactive
poly-L-ketoacyl thioester intermediate before polyaromatic
cyclization can take place. Oxidation of 5-deoxyenterocin
to enterocin would require the second oxygenase. Two
candidate oxygenase encoding genes, an unusual £avin-de-
pendent monooxygenase and a cytochrome P-450 hydrox-
ylase encoded by encM and encQ, respectively, are located
downstream of the minimal enc PKS on separate transcripts.
EncM is similar to a group of oxygenases that contain co-
valently bound £avin-adenine dinucleotide (FAD) (Figure
5). Position 78 contains a conserved histidine residue,
which is the FAD-binding site in homologous proteins
such as 6-hydroxy-D-nicotine oxidase from Arthrobacter oxi-
dans [23]. Other members of this uncommon class of en-
zymes include McrA [24], MmcM, and MitR [25], which
are involved in the resistance and biosynthesis of mitomy-
cin, DnrW from the daunorubicin biosynthesis cluster (ac-
cession number AAD00354), and the berberine bridge en-
zyme from plants [26]. The diverse oxidative reactions
catalyzed by these enzymes are often not well understood
and unfortunately provide no direct indication of the func-
tion of EncM. The second putative oxygenase is encoded
by encR. The deduced protein shows good homology to
hydroxylases of the cytochrome P-450 family. Its sequence
displays characteristic P-450 motifs [27], including the
highly conserved consensus sequences associated with
heme and oxygen-binding sites. The essential cysteine res-
idue that serves as the heme iron ligand is positioned at aa
350. Downstream and apparently translationally coupled to
encR by a probable 7 nt overlap lies encQ. This ORF is
probably translated into a ferredoxin-type protein of 81
aa in length and is most similar to RapO from the rapamy-
Figure 5. Alignment of homologues to EncM around the conserved FAD-binding histidine. Sequence identi¢cation codes are Smari^EncM,
`S. maritimus' EncM; Bsubt^YgaK, Bacillus subtilis hypothetical protein YgaK (accession number CAB04812); Bsubt^YvdP, B. subtilis
hypothetical protein YvdP (CAB08045); Mtu^Rv1736, Mycobacterium tuberculosum hypothetical protein Rv1736 (CAB03710); Slave^McmM,
Streptomyces lavendulae McmM (AAD32736); Slave^MitR, S. lavendulae MitR (AAD28454); Aox^6HDNO, A. oxidans 6-hydroxy-D-nicotine
oxidase (448109); Ath^F19I3, Arabidopsis thaliana putative berberine bridge enzyme (AAD25758); Speuc^DnrW, Streptomyces peucetius
DnrW (AAD00354).
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cin biosynthetic gene cluster [28]. Of the four possible
iron-binding cysteine residues, three are present in the
protein sequence at positions 21, 27 and 62. As with
RapO, the fourth active site cysteine residue at position
24 is exchanged against serine. The coupling of encR and
encQ implies that EncQ is involved in the reoxidation of
EncR. A gene encoding an NADPH-ferredoxin reductase,
the second enzyme necessary for P-450 reoxidation, was
not found in the enc cluster and is probably supplied by
primary metabolism.
The gene product of encK, which neighbors the putative
KR, shows high homology to a protein from E. coli with
unknown function (accession number P77460) and weaker
homology to a phosphatidylethanolamine N-methyltrans-
ferase from Acetobacter aceti (accession number
BAA34057). A probable S-adenosyl methionine-binding
motif between positions 61 and 165 was identi¢ed (PRO-
SITE: PS50193) that is characteristic for methyltransfer-
ases. EncK could thus be responsible for the introduction
of the O-methyl groups of enterocin and the wailupemy-
cins A^C. If so, this enzyme is remarkably versatile having
the ability to methylate K-pyrone units belonging to sig-
ni¢cantly different substrates.
Regulatory and resistance genes
EncE resembles regulatory proteins of the MerR family.
These proteins bind DNA through an N-terminal helix-
turn-helix motif and turn into transcriptional activators
upon binding to an inducer [29]. Separated from encE by
a gap of 850 nt lies encF. The predicted protein is highly
similar to transcriptional activators of the Streptomyces anti-
biotic regulatory protein (SARP) family, which are involved
in morphological differentiation and in the regulation of
secondary metabolism [30]. encF is similar to SARP genes
from other type II PKS clusters, such as actII-ORF4 [31]
and frnG [32]. During secondary metabolism, SARPs bind
to repeats of speci¢c DNA sequences to enhance the in-
teraction of promoter regions with RNA polymerases. Re-
peats that could be potential binding sites for EncF were
identi¢ed between the divergent ORFs encF and encG (i.e.
a tetramer of C[GA][GC]TGG). A third protein with po-
tential regulatory function is encoded by encS and contains
a putative helix-turn-helix motif at aa 52^67 and a motif
common to transcriptional repressors of the TetR family
(Pfam: PF00440). Divergently transcribed from EncS,
EncT strongly resembles ef£ux proteins involved in resis-
tance mechanisms [33]. Several other determinants of re-
sistance against antibiotics have been shown to consist of
such divergent repressor^resistance gene pairs [34,35]. As
in these systems, a region with dyad symmetry is present
between encS and encT that probably functions as the bind-
ing site for the repressor. encF (63.5%) exhibits low GC
content and contains a number of codons that are rare in
Streptomyces [36]. A rare TTA codon, which is present in
many SARP genes and is known to play a role in Strepto-
myces regulation and resistance [37], is present in encT.
However no such codon is present in the SARP homo-
logue encF.
Genes of unknown function
EncG is homologous to a family of proteins found in sev-
eral type II PKS pathways, including MtmX (mithramycin)
[38], DpsH (daunorubicin) [39], ActVI-ORFA (actinorho-
din) [40], and Gra-ORF31 (granaticin) [41]. The encG ho-
mologues MtmX and DpsH have been implicated in the
cyclization process of the linear polyketide [42,43], whereas
actVI-ORFA has recently been proposed to stabilize the
multicomponent, type II PKS complex and assist in pyran
ring formation [44]. The putative gene product of the short
ORF encO does not resemble any protein in the databases.
In vivo expression and functional analysis of encD
Sequence analysis of encD suggests a functional role of the
Figure 6. LC-APCI-MS traces of
engineered polyketides from (1) S. lividans
K4-114 (pSEK4), (2) S. lividans K4-114
(pSEK4/pCH20), and (3) S. lividans K4-
114 (pRM5). HPLC was monitored at 254
nm. Chromatographic peaks labeled with
letters `a' (MH = 301) and `b' (MH = 285)
are uncharacterized polyketides.
CHBIOL 43 30-3-01
Research paper Derailment of an aromatic polyketide synthase Piel et al. 949
gene product in the reduction of the C-9 carbonyl in the
linear polyketide before rearrangement and subsequent
cyclization (Figure 1). The apparent function of EncD is
equivalent to other KRs associated with type II PKS sys-
tems, including ActIII, which catalyzes a similar reduction
in actinorhodin biosynthesis [45]. In order to evaluate
whether EncD is functionally equivalent to ActIII, we con-
structed the encD containing plasmid pCH20 and co-ex-
pressed it with pSEK4 [46] in the host strain S. lividans
K4-114. pCH20 is based on the integrating bacteriophage
plasmid pSET152 and was constructed by cloning a 0.9 kb
FseI^NsiI fragment from the ‘S. maritimus’ cosmid clone
pSS9A6 into the pSET152 derivative pKOS010 [47]. The
expression vector pSEK4 harbors the act PKS genes actI-
ORFs 1^3, actVII, and actIV and is related to pRM5 which
additionally carries the activated actIII KR [46]. Liquid
chromatography (LC)-APCI-mass spectrometry (MS) anal-
ysis of organic extracts from S. lividans K4-114 (pSEK4/
pCH20) and K4-114 (pRM5) gave nearly identical pro¢les
(Figure 6), thus verifying that EncD is a KR of similar
function as ActIII. As expected [48], 3,8-dihydroxymethyl-
anthraquinone carboxylic acid and the decarboxylated
product aloesaponarin II were identi¢ed by LC-MS analy-
sis of the S. lividans K4-114 (pSEK4/pCH20) and K4-114
(pRM5) extracts, along with several other known and pos-
sibly new analogues.
Overproduction and functional analysis of EncR
In order to evaluate which oxidative reaction is catalyzed
by the putative cytochrome P-450 hydroxylase EncR, we
¢rst incubated ‘S. maritimus’ with the monooxygenase in-
hibitor ancymidol [49]. This experiment resulted in the
accumulation of 5-deoxyenterocin with concomitant loss
of enterocin production, suggesting that the ¢nal reaction
in enterocin biosynthesis involves a P-450-catalyzed hy-
droxylation of 5-deoxyenterocin. In a series of cell-free
transformations, 5-deoxyenterocin was converted to enter-
ocin under cytochrome P-450 conditions. The cell-free ex-
tract of ‘S. maritimus’ was prepared from mycelia obtained
after passage of cells through a French press. The desalted
ammonium sulfate fraction was incubated with 5-deoxyen-
terocin in the presence of NADPH and the P-450 electron
transport proteins ferredoxin and ferredoxin-NADP re-
ductase. Products were analyzed by LC-MS, isolated by
preparative thin layer chromatography, and compared
with authentic standards of deoxyenterocin and enterocin
by nuclear magnetic resonance.
The gene encoding EncR was initially cloned into the
protein expression plasmid pRSETb. Unfortunately, ex-
pression of the poly-histidine-tagged EncR resulted in
large quantities of insoluble protein and efforts to solubi-
lize the protein were unsuccessful. EncR was alternatively
cloned into pMAL-c2x, introducing a maltose-binding-pro-
tein (MBP) af¢nity tag at the amino-terminus. The result-
ing MBP-EncR fusion protein was puri¢ed on an amylose
resin column (Figure 7) and showed a requirement for
ferredoxin, ferredoxin-NADP reductase, and NADPH.
LC-MS analysis of the reaction products demonstrated
conversion of 5-deoxyenterocin to enterocin (Figure 7),
thus establishing EncR as a 5-deoxyenterocin hydroxylase.
Furthermore, MBP-EncR was inhibited by ancymidol, con-
Figure 7. (A) SDS^polyacrylamide gel
showing the MBP-EncR puri¢ed protein
preparation. Lane 1: molecular weight
markers; lane 2: cell-free preparation; lane
3: MBP-EncR (calculated molecular weight
is 86.6 kDa). (B) HPLC traces of
standards 5-deoxyenterocin (chromatogram
1) and enterocin (chromatogram 2) and the
MBP-EncR catalyzed reaction mixture
(chromatogram 3).
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¢rming that the earlier observation at the in vivo level was
due to ancymidol inhibition of the cytochrome P-450
EncR.
Discussion
In the work presented here, we report the sequence of the
enterocin biosynthesis gene cluster that spans 21.3 kb and
involves 20 ORFs (Figure 2). A detailed sequence analysis
of the enc gene set revealed several features that are un-
precedented in type II PKS catalyzed polyketide assembly
and supports a proposed model of biosynthesis to this un-
usual set of metabolites (Figure 1). Novel biochemical fea-
tures discussed at length below include the observed spon-
taneity of the biosynthetic pathway, the carbon
rearrangement of the linear poly-L-carbonyl intermediate,
and the biosynthesis and attachment of the uncommon
benzoate starter unit.
The enc gene set contains the typical arrangement of the
three components KSK, KSL, and ACP that comprise a
minimal PKS. The ¢rst noticeable architectural departure
of the enc cluster from all other type II PKS gene sets is the
absence of cyclase and aromatase encoding genes. This
key difference is mirrored in the diverse series of novel
metabolites that uniquely arise from the enc encoded path-
way [3]. Cyclases act as chaperones in catalyzing the cyc-
lization of the labile poly-L-carbonyl intermediate away
from a myriad of chemically feasible reaction products
and into a single polycyclic aromatic product. When cy-
clases are unnaturally removed from their coupled minimal
PKS, spontaneous chemistry can result as the minimal PKS
relies on the stabilizing effects of the cyclase and other
subunits to ensure directed assembly [50]. Thus, the nat-
ural absence of cyclases in the enc system provides molec-
ular support for the metabolic diversity in this pathway as
well as in engineered systems in which cyclases have been
unnaturally removed [51].
The second unprecedented feature in this pathway in-
volves the derailment of the aromatization of the highly
reactive poly-L-carbonyl intermediate by a Favorskii-like
rearrangement to yield non-aromatic polyketide products.
This rare metabolic process has been proposed on the
basis of labeling experiments in only a few other natural
product pathways [52^54] and conceivably involves the
action of an oxygenase. Taking the oxidative nature of
this carbon rearrangement into account, the £avin-depen-
dent oxygenase EncM is a probable candidate for catalyz-
ing this reaction as the cytochrome P-450 EncR rather
catalyzes the hydroxylation of 5-deoxyenterocin. The £avin
oxygenase EncM has been tentatively assigned as the
‘favorskiiase’ and its role in this reaction is under evalua-
tion. Interestingly, a similar proposal has been presented in
dino£agellate polyether biosynthesis to account for the in-
terrupted pattern of acetate units in the polyketide chain
[54].
We propose that the unprecedented K-oxidation and Fa-
vorskii rearrangement take place on the linear octaketide.
The single oxygenase probably complexes with the mini-
mal enc PKS since poly-L-ketides are notoriously reactive
[50] and would likely spontaneously cyclize if passed onto
a non-associated protein. The rearrangement, however,
probably occurs after the EncD-catalyzed C-9 ketoreduc-
tion to account for the formation of wailupemycin D, a
probable misadventure byproduct. This compound is struc-
turally related to the act/whiE recombinant product EM18
(Figure 1) [55] and provides further evidence that the en-
terocin family of polyketides is derived from a rearrange-
ment of a linear poly-L-ketide. In addition to catalyzing the
Favorskii-like rearrangement, the favorskiiase may ‘cata-
lyze’ the cyclization of the branched intermediate by limit-
ing its conformational mobility to allow intramolecular aldol
condensations and provide the carbon skeleton of the ma-
jor metabolite enterocin. Spontaneous decarboxylation and
cyclization of this highly labile intermediate would account
for the branch in the pathway to provide the minor by-
products 3-epi-5-deoxyenterocin and wailupemycins A^C.
Another enzyme involved in post-polyketide assembly is
the highly versatile methyltransferase EncK. This enzyme
putatively has the remarkable ability to methylate signi¢-
cantly different substrates. The aberrant metabolite wailu-
pemycin D is the only member in the characterized series
whose K-pyrone ring is not methylated. EncK may alter-
natively act on an early general intermediate, implying an
early release from the PKS. This scenario would necessi-
tate that all cyclization events are post-assembly on the
unbound substrate.
A third novel feature of the enc pathway involves the ben-
zoate starter unit. The vast majority of type II PKSs utilize
acetate as a starter unit. The exceptions identi¢ed to date
include daunorubicin (propionate) [21], oxytetracycline (ei-
ther malonamide or malonate) [56], R1128A^D (acetate,
propionate, isobutyrate, and butyrate) [57], and putatively
frenolicin (butyrate) [22]. Enterocin with its benzoate start-
er unit is the ¢rst aromatic addition to this limited set of
aliphatic starter units. The process of starter unit selection
is not well understood and does not seem to be catalyzed
by homologous enzymes in each pathway. A conceivable
mechanism could be the activation of the starter acid by an
acyl-CoA ligase and the subsequent loading onto the ACP
by an AT. In accordance with this proposal, AT genes have
been found in the oxytetracycline, daunorubicin, R1128,
and frenolicin clusters, while a dedicated AT is absent in
all known clusters involved in the biosynthesis of acetate-
primed polyketides. In addition to an AT, the daunorubi-
cin cluster uniquely contains a L-ketoacyl:ACP synthase
III that is involved in starter unit selection [58,59]. An
acyl-CoA ligase gene has so far only been reported in the
oxytetracycline cluster [56], and the expression of a subset
of oxytetracycline genes missing both the CoA ligase and
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the AT resulted in the production of acetate-primed com-
pounds [56]. The starter unit selection in enterocin biosyn-
thesis is probably determined more similarly to oxytetracy-
cline than to daunorubicin or R1128, as the enterocin
cluster contains genes homologous to an aryl-CoA ligase
and an AT.
Benzoic acid is a very rare bacterial metabolite and has
been implicated in only one other bacterial secondary met-
abolic pathway where it serves as a primer unit for the
soraphen A modular type I PKS [60]. Two benzoate path-
ways have been characterized in plants and fungi, which
involve conversion of phenylalanine to trans-cinnamic acid
by PAL (Figure 3). The routes diverge at this intermedi-
ate, one involving a L-oxidation pathway (route A) and the
second a retro-aldol path through benzaldehyde (route B).
The only known bacterial benzoate pathway is anaerobic
and involves transamination of phenylalanine to phenylpyr-
uvate followed by two successive K-oxidative decarboxyla-
tions [61].
Several ORFs putatively involved in the biosynthesis of
the enterocin benzoyl-CoA starter unit are arranged on
either side of the minimal enc PKS. Sequence analysis sup-
ports the involvement of a plant-like benzoate pathway,
and feeding experiments with labeled precursors support
the L-oxidation route (Figure 3, route A) as all of the pro-
posed intermediates enriched enterocin with high incorpo-
ration rates [13]. The conversion of phenylalanine through
trans-cinnamic acid to benzoate, although very common in
plants and fungi, has not been reported in bacteria. The
initial biosynthetic step putatively involves a bacterial PAL
catalyzed conversion by the encP gene product. Although
ubiquitous in plants and in some fungi, surprisingly neither
PAL nor its encoding gene has been isolated from bacteria.
A PAL was, however, detected in a cell-free preparation of
Streptomyces verticillatus as a component of cinnamamide
biosynthesis [62]. Activation of cinnamic acid to its CoA
thioester by the acyl-CoA ligase EncH followed by a series
of L-oxidation reactions would directly provide the benzo-
yl-CoA primer unit (Figure 3, route A). Two of the three
L-oxidation enzymes were identi¢ed on the sequenced
fragment, a hypothetical enoyl-CoA hydratase (EncI) and
a L-ketothiolase (EncJ). A dedicated L-hydroxyacyl-CoA
dehyrogenase, however, is absent. This ¢nding may imply
that this protein is encoded on an unsequenced region of
the cluster or on a different part of the chromosome and
is functionally substituted by a resident dehydrogenase
from the host S. lividans K4-114. Alternatively, the oxygen-
ase EncM may have dual functions and additionally cata-
lyze the dehydrogenation reaction. The occurrence of an
aryl-CoA ligase (EncN) appears redundant, as L-oxidation
of cinnamyl-CoA should directly yield benzoyl-CoA. Suc-
cessful incorporation of d5-benzoic acid into enterocin [3]
suggests that EncN is indeed functional. It remains to be
elucidated whether the thiolase EncJ directly generates
benzoate or its CoA thioester and whether the EncN ligase
accepts benzoate from an additional metabolic source.
Further analysis with recombinant proteins is presently
underway and will shed further light on benzoic acid bio-
synthesis in ‘S. maritimus’ and, by analogy, in plants and
fungi.
Signi¢cance
The enc gene cluster encodes a novel polyketide biosyn-
thetic pathway that yields the structurally diverse set of
enterocins and wailupemycins. At least 12 different struc-
tures with more than ¢ve distinct cyclization patterns result
from this single biochemical pathway. The cloning and
sequencing of this iterative type II biosynthetic gene set
revealed several unprecedented features that account for
its programmed spontaneity and novel structural character-
istics. Absence of cyclases and aromatases normally associ-
ated with type II PKS clusters provides the molecular ra-
tionale for the observed reactivity as unnatural aromatic
PKS systems without these gene products similarly pro-
duce randomly cyclized products. The Favorskii-like rear-
rangement is the probable cause for the prevention of the
minimal enc PKS product from yielding an aromatic product
and is putatively catalyzed by the oxygenase EncM. A
route for the biosynthesis and attachment of the rare ben-
zoate starter unit is proposed and involves the ¢rst prokary-
otic PAL. These novel features provide a distinct oppor-
tunity to engineer structurally diverse ‘unnatural’ natural
products for use in drug discovery by engineering hybrid
expression systems with typical aromatic PKS genes, such
as those from the actinorhodin, tetracenomycin and dauno-
rubicin clusters. The engineered biosynthesis of act PKS
products in a streptomycete transformant carrying act and
enc genes on separate plasmids indicates for the ¢rst time
that a multiplasmid approach with type II PKS genes is a
viable and powerful technique for engineering novel prod-
ucts [63]. This study also represents the ¢rst example of a
sequenced marine bacterial natural product biosynthetic
gene cluster and its heterologous expression.
Materials and methods
Bacterial strains, plasmids, culture conditions and DNA
manipulations
`S. maritimus' was a gift from Dr. Bradley S. Davidson (Utah State
University). For sporulation, it was grown on A1 plates for 7 days at
30³C. E. coli XL1-Blue was used for subcloning and grown on LB plates
or in LB liquid medium. E. coli SURE was used for cosmid library con-
struction and was grown in LBMM liquid medium and on LB plates.
pNFPK-4, pNFPK-7, and pHGF7516 were kindly provided by Dr. Tin-
Wein Yu (University of Washington), and pRM5 [46] and pSEK4 by Dr.
Chaitan Khosla (Stanford University). The expression plasmid
pKOS010-153 [47] and the host S. lividans K4-114 [9] were kindly pro-
vided by Drs. Robert McDaniel and Mary C. Betlach, respectively, Ko-
san Biosciences, Inc., Hayward, CA, USA. pBluescript SK(3) (Strata-
gene) was used as vector for cloning in E. coli and for sequencing.
SuperCos (Stratagene) and pOJ446 [64] were used for cosmid library
construction. Strain and DNA manipulations as well as Southern hybrid-
ization were performed according to standard procedures [65,66].
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Cosmid library construction and screening
SuperCos was digested with XbaI, dephosphorylated with shrimp alka-
line phosphatase, and digested with BamHI. `S. maritimus' genomic
DNA was partially digested with Sau3AI and dephosphorylated. Ge-
nomic DNA was partially digested with Sau3AI and dephosphorylated.
DNA with a high content of fragments between 25 and 35 kb (about 2^3
Wg) was isolated by agarose gel electrophoresis and used for ligation to
about 400 ng vector. Ligation was carried out overnight at 16³C using
T4 DNA ligase. Packaging and titration were done using the Gigapack II
XL kit (Stratagene) according to the manufacturer's instructions. After
selection with carbenicillin (100 Wg/ml), V2000 colonies were picked
and grown overnight in 96-well plates. Cultures were transferred to a
Hybond-N membrane (Amersham Pharmacia Biotech) and grown over-
night on LB agar medium containing carbenicillin. DNA was denatured
and ¢xed according to standard procedures. For construction of the
pOJ446 library, pOJ446 was digested with HpaI, dephosphorylated,
and digested with BamHI. Further construction was as described for
SuperCos, except that apramycin (100 Wg/ml) was used for selection.
These libraries were screened with digoxigenin-labeled actI-ORF1 (ob-
tained from pNFPK-4) and actIII (obtained from pNFPK-7) probes and
32P-labeled encP (0.8 kb XmaI fragment from encP). Digoxigenin label-
ing and detection of digoxigenin-labeled positives were performed with
the DIG High Prime DNA Labeling and Detection Starter kit II (Boehr-
inger Mannheim).
Expression of enterocin-wailupemycin products
Protoplasts were prepared from S. lividans K4-114 and transformed with
pJP15F11 according to standard procedures [66]. After protoplast re-
generation became visible (12^15 h), plates were overlaid with apramy-
cin at 1 mg/plate. Four colonies were grown on fresh plates, and cells
were used for isolation of cosmid DNA. The cosmids were ampli¢ed in
E. coli, isolated and checked by restriction analysis. S. lividans K4-114/
pJP15F11-1 was selected for expression studies and grown on R2YE
agar plates containing 100 Wg/ml apramycin for 1 week. Chemical anal-
ysis of the expressed products was previously described [3].
DNA sequencing
Sequencing was carried out by the dideoxynucleotide chain termination
method with BigDye Terminator Ready Mix (Applied Biosystems) and
using an ABI 377X2 sequencer (Applied Biosystems). Cosmid pSS9A6
and pBluescript SK(3) containing inserts of pSS9A6 fragments gener-
ated by digestion with BamHI, SacII or XmaI were used for sequencing.
Both DNA strands were sequenced using the T3 and T7 universal prim-
ers or with internal primers. Computer-aided database searching and
sequence analyses were performed using the BLAST algorithm [67],
MacFRAME (version 1.2, developed by Kevin Kendall (Tulane Univer-
sity, New Orleans, LA, USA)), and ClustalX.
Construction of pCH20
pCH20 is a derivative of pKOS010-153 [47], in which the PacI^EcoRI
eryAIII fragment was replaced by a 0.9 kb PacI^EcoRI encD fragment.
PacI and EcoRI were introduced by cloning the 0.9 kb FseI(blunt)^NsiI
fragment of pSS9A6 into the EcoRV^NsiI sites of pHGF7516, a deriva-
tive of pNEB193 (New England Biolabs) carrying a modi¢ed polylinker.
Streptomyces transformation, culture conditions, and MS
analysis of polyketides
S. lividans K4-114 transformants were prepared according to standard
procedures with thiostrepton and apramycin in R2YE protoplast regen-
eration plates [66]. Protoplasts were transformed singly with pRM5 and
pSEK4 and doubly with pSEK4 and pCH20. The strains were grown on
R2YE agar plates overlaid with thiostrepton (0.5 mg/plate) and/or apra-
mycin (1 mg/plate) at 30³C for 1 week. The cultured agar from one plate
(ca. 25 ml) was chopped and extracted with 95:5 EtOAc/MeOH (50 ml)
at room temperature for 1^2 h. The organic solution was dried
(Na2SO4), ¢ltered, solvent-evaporated, dissolved in MeOH, and ana-
lyzed. A Hewlett Packard 1050 series high performance liquid chroma-
tography (HPLC) system was linked to a Finnigan MAT TSQ 7000 mass
spectrometer, using atmospheric pressure chemical ionization and op-
erating in the positive ion mode. A Vydac 218TP52 4.6U200 mm C18
column was used at a £ow rate of 0.2 ml/min with a linear solvent
gradient of 0.15% tri£uoroacetic acid (TFA) in water to 0.085% TFA in
acetonitrile over a period of 40 min.
Ancymidol inhibition of enterocin biosynthesis
Five £asks containing 100 ml A1 medium were inoculated with 10 ml of
fresh overnight `S. maritimus' culture. 100 Wl of DMSO was added at the
time of inoculation to one £ask as a control, three of the remaining £asks
had ancymidol added to 0.2, 0.8, and 2 mM ¢nal concentration, and the
¢nal £ask received no additions. These cultures were incubated for
7 days at 28³C, 200 rpm. EtOAc fractions (100 ml) were dried (MgSO4),
evaporated in vacuo, dissolved in MeOH (500 Wl), and analyzed (5 Wl)
by HPLC (4.6U150 mm YMC ODS-AQ S3 120A column; £ow rate of
0.5 ml/min with a linear solvent gradient of 40% MeOH in 0.15% TFA^
water to 100% MeOH over 30 min).
`S. maritimus' cell-free conversion of 5-deoxyenterocin to
enterocin
Cells from a 5 day culture of `S. maritimus' in 1 l A1 media were har-
vested by centrifugation and resuspended in 100 mM phosphate buffer,
pH 7.2, containing 20% v/v glycerol, 0.2 mM PMSF, 1 mM EDTA, and
0.2 mM dithiothreitol. The cells were lysed by a single passage through
a French pressure cell, and polyethylene imine was added to a ¢nal
concentration of 0.2%. The resulting suspension was centrifuged at
35 000Ug for 35 min. The supernatant was removed and adjusted to
75% (NH4)2SO4 saturation. The protein precipitate was resuspended in
3 ml 100 mM phosphate buffer, pH 7.2, containing 20% glycerol, de-
salted by gel permeation chromatography, and assayed.
100 Wl of enzyme solution (0.1^0.3 mg total protein) was added to a 0.9
ml solution containing 0.01 Wmol spinach ferredoxin, 0.17 Wmol NADPH,
10 nmol 5-deoxyenterocin, 0.1 U ferredoxin-NADP reductase, and 20
mM Tris pH 7.4. The reaction was incubated for 2 h at 30³C and then
extracted with EtOAc (3U0.5 ml). The organic fractions were combined,
dried (Na2SO4), and the solvent removed in vacuo. The resulting pellet
was resuspended in MeOH (20 Wl) and analyzed (5 Wl) as above by
HPLC.
Overproduction and biochemical characterization of EncR
EncR was ampli¢ed by PCR from the cosmid clone pJP15F11 with
primers P450pstf (5P-GACTGCAGACCACCCATACCCAG-3P) and
P450hinr2 (5P-CTAAGCTTTCACCACTTCACCGGCAG-3P). (The intro-
duced PstI and HindIII restriction sites are underlined, respectively.)
The ampli¢ed product was digested and cloned into the PstI^HindIII
sites of pMAL-c2x (NEB) to yield pPS006. Introduction of pPS006 into
E. coli TB1 under standard expression conditions resulted in the pro-
duction of MBP-EncR. The soluble fraction of the fusion protein was
partially puri¢ed on an amylose resin af¢nity column (NEB). Cytochrome
P-450 assays were performed as above. Ancymidol inhibition was mea-
sured at 0.2, 0.8, and 2 mM concentrations.
Accession numbers
The GenBank accession number for the enc cluster is AF254925.
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